Behaviour therapy for obsessive-compulsive disorder: a decade of progress
- PMID: 9469234
- DOI: 10.1177/070674379704201002
Behaviour therapy for obsessive-compulsive disorder: a decade of progress
Abstract
Objective: To review the last decade of behaviour therapy research in obsessive-compulsive disorder (OCD).
Method: The most salient research was analyzed.
Results: Many studies confirmed that exposure and ritual prevention (ERP) effectively reduced compulsive rituals and obsessive thoughts in most patients in all age groups, although a minority of the patients did not complete treatment. Gains persisted to follow-up 2 to 6 years later in several countries. Improvement after ERP generalized to obsessive-compulsive beliefs, mood, work, and social adjustment, and was accompanied by reduction in cerebral blood flow in the right caudate nucleus. Teaching patients how to prevent relapse seems to reduce the risk of recurrence. ERP yields slightly more improvement than does appropriate antidepressant medication and is followed by far less relapse after treatment has stopped, so ERP may be more cost-effective in the long term. Antidepressant medication is a useful adjunct to ERP when OCD is accompanied by comorbid depression. The therapist now tends to teach patients how to carry out self-exposure and self-imposed ritual prevention, rather than to impose ERP on them. Self-help manuals help patients to do this, and computer aids to allow patients to learn how to do ERP at home have been valuable in pilot studies. Cognitive therapy without ERP was as useful as ERP.
Conclusion: ERP is of lasting value for OCD. Long-term cost-effectiveness comparisons are needed of self-administered ERP versus cognitive therapy and versus medication. Studies are also needed of brief psychological treatment for depression comorbid with OCD.
Similar articles
-
Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.J Clin Psychiatry. 2010 Sep;71(9):1158-67. doi: 10.4088/JCP.08m04990blu. Epub 2010 Mar 23. J Clin Psychiatry. 2010. PMID: 20361906 Clinical Trial.
-
A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials.Behav Ther. 2007 Jun;38(2):179-91. doi: 10.1016/j.beth.2006.07.001. Epub 2007 Jan 23. Behav Ther. 2007. PMID: 17499084 Clinical Trial.
-
The psychological treatment of obsessive-compulsive disorder.Can J Psychiatry. 2006 Jun;51(7):407-16. doi: 10.1177/070674370605100702. Can J Psychiatry. 2006. PMID: 16838822 Review.
-
[A standardized cognitive-behavioural group treatment program for obsessive compulsive disorder: preliminary outcomes].Encephale. 2002 Sep-Oct;28(5 Pt 1):439-46. Encephale. 2002. PMID: 12386546 French.
-
Efficacy of cognitive-behavioral therapy for obsessive-compulsive disorder.Psychiatry Res. 2015 Feb 28;225(3):236-46. doi: 10.1016/j.psychres.2014.11.058. Epub 2014 Dec 8. Psychiatry Res. 2015. PMID: 25613661 Review.
Cited by
-
Clinical treatment of obsessive compulsive disorder.Psychiatry (Edgmont). 2005 Nov;2(11):34-43. Psychiatry (Edgmont). 2005. PMID: 21120095 Free PMC article.
-
Unified protocol for the discontinuation of long-term serotonin reuptake inhibitors in obsessive compulsive disorder: Study protocol and methods.Contemp Clin Trials. 2018 Feb;65:157-163. doi: 10.1016/j.cct.2017.12.017. Epub 2018 Jan 3. Contemp Clin Trials. 2018. PMID: 29306047 Free PMC article.
-
Enhancing Emotion Regulation and Overcoming Craving in Alcohol Dependence Syndrome Through Mindfulness-based Relapse Prevention.Indian J Psychol Med. 2024 May 26:02537176241246332. doi: 10.1177/02537176241246332. Online ahead of print. Indian J Psychol Med. 2024. PMID: 39564294 Free PMC article.
-
Decoding moral emotions in obsessive-compulsive disorder.Neuroimage Clin. 2018 Apr 4;19:82-89. doi: 10.1016/j.nicl.2018.04.002. eCollection 2018. Neuroimage Clin. 2018. PMID: 30035005 Free PMC article.
-
Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.Subst Abus. 2009 Oct-Dec;30(4):295-305. doi: 10.1080/08897070903250084. Subst Abus. 2009. PMID: 19904665 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical